MedCity News April 27, 2021
Too many cold chain suppliers are still monitoring deliveries and storage compliance with paper-based documentation by individuals scanning thermometers every two hours. Such systems fall short of 21st-Century requirements for biologic medicine.
With the medical supply chain shifting to high gear, delivering millions of Covid-19 vaccines to an anxious and eager population, it’s easy to miss the long-term challenge brewing beneath the surface of the immediate rollout. First, we must recognize that the manufacture and rollout of messenger ribonucleic acid (mRNA) treatments on such a massive, industrial scale represents the biggest medical breakthrough of our lifetime. However, the ongoing response to the global pandemic has revealed serious vulnerabilities in the pharmaceutical industry’s fragmented infrastructure of cold chain storage and delivery...
Today's Sponsors
Today's Sponsor